LNSR LENSAR, Inc.

$8.24 -3.00%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

LENSAR, Inc. (LNSR) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $101 million. Shares last traded at $8.24, 36.3% below their 52-week high. Over the past year the stock is down 31.7%. LNSR trades at a price-to-earnings ratio of 2.92, below the Surgical & Medical Instruments & Apparatus median of 28.18. Net profit margin is 64.8%, above the peer median of -9.3%. Revenue grew 12.4% year over year.

Market Cap

$101M

Shares Out

12.3M

EPS (TTM)

$-4.60

P/E Ratio

2.92

P/S Ratio

1.89

P/B Ratio

6.80

Dividend / Share

—

Dividend Yield

—

52-Week High

$12.94

52-Week Low

$4.94

Volume

4,583

Avg Vol (3m)

4,183.444

Performance

-2.66%

+43.52%

+46.71%

-32.00%

YTD

-28.74%

-31.69%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

60.13

SMA (50)

$6.64

SMA (200)

$8.33

Price vs SMA50

+24.17%

Price vs SMA200

-1.07%

ATR (14)

$0.34

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$54M

Net Income

$35M

Gross Margin

41.9%

Operating Margin

-15.2%

Net Margin

64.8%

Return on Equity

232.8%

Return on Assets

49.9%

Current Ratio

2.39

Debt / Equity

2.74

Revenue Growth (YoY)

+12.4%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$0.61	2026-08-13
Q1 2026	$0.00	2026-05-08
FY 2025	$-2.87	2026-03-31
Q3 2025	$-2.75	2025-11-06
Q2 2026	$-2.46	2026-08-13
Q1 2026	$-2.32	2026-05-08

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

LNSR vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/E vs peers

2.92 / 28.18 med

-90% discount

P/S vs peers

1.89 / 2.94 med

-36% discount

Net margin vs peers

64.8% / -9.3% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.